Thursday, 19 February 2026

Regulating AI: A Thoughtful Approach?

›
Tom Wheeler at the Brookings Institution has published an excellent short paper titled, “Governing the AI Transition: Lessons from the 1996 ...
Wednesday, 18 February 2026

US FTC Sends Letter to Data Brokers concerning Disclosing Sensitive Data to Foreign Adversaries

›
The Federal Trade Commission has sent a warning letter to Data Brokers about violating the Protecting Americans’ Data from Foreign Adversari...
Wednesday, 11 February 2026

Jury Convicts Former Google Engineer of Economic Espionage concerning AI

›
The U.S. Department of Justice has announced in a press release the conviction of a former Google software engineer of economic espionage co...

US DOJ files action requiring divestiture by Chinese Company of U.S. Company

›
The U.S. Department of Justice has filed a complaint against China based Suirui Group’s acquisition of California’s Jupiter Systems based on...
Wednesday, 24 December 2025

USPTO Proposes Rule Requiring Representation by Registered USPTO Practitioner for All Foreign Applicants and Patent Owners

›
The United States Patent and Trademark Office issued a press release concerning a new rule regarding foreign applicants and patent owners th...
Monday, 22 December 2025

Trump Executive Order Attempts to Stymie State AI Legislation

›
On December 11, 2025, President Trump issued an Executive Order titled, “Ensuring a National Policy Framework for Artificial Intelligence.” ...
Wednesday, 17 December 2025

U.S. National Institute for Standards and Technology Releases Cybersecurity Framework Profile for AI

›
The U.S. National Institute for Standards and Technology has released the draft, “Cybersecurity Framework Profile for Artificial Intelligenc...
Thursday, 11 December 2025

USPTO Issues New Guidance on AI Assisted Inventions

›
The USPTO has rescinded its prior guidance on AI assisted inventions which relied on the Pannu factors when determining if a human sufficien...

Teva Pharmaceuticals will remove over 200 improper patent listings from the Orange Book

›
On December 10, 2025, the FTC announced that Teva Pharmaceuticals will “[r]emove. . .  Over 200 Improper Patent Listings” to improve generic...